Stock 4114 SYNMOSA BIOPHARMA CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Synmosa Biopharma Corporation

Equities

4114

TW0004114004

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
39.95 TWD +0.25% Intraday chart for Synmosa Biopharma Corporation +1.01% +3.36%
05-15 Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-29 Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Synmosa Biopharma Corporation Announces Changes in Fifth Session of the Remuneration Committee
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Synmosa Biopharma Corporation Announces Cash Dividend, Payable on September 15, 2023
CI
Synmosa Biopharma Corporation Appoints Tu, San-Chien as Additional Independent Director
CI
Synmosa Biopharma Corporation Appoints Tu, San-Chien as Member of the Audit Committee
CI
Synmosa Biopharma Corporation announced that it expects to receive TWD 950 million in funding
CI
Synmosa Biopharma Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Synmosa Biopharma Corporation Approves Dividend for the Year Ended December 31, 2022
CI
Synmosa Biopharma Corporation Announces Changes of Corporate Governance Officer
CI
Synmosa Biopharma Corporation Provides Earnings Guidance for the Year 2022
CI
Synmosa Biopharma Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Synmosa Biopharma : The Company is invited to attend institutional investor conference held by IBF Securities
PU
Synmosa Biopharma Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Synmosa Biopharma : To announces SYNMOSA board of directors has lifted the restriction on the prohibition of competition for managerial officer
PU
Synmosa Biopharma : The Company's 2022 Second quarter consolidated financial statements have been reported to the Board
PU
Synmosa Biopharma : Announcement of the Company's adjustment of the number for the transfer treasury shares to employees through the resolution of the board of directors on 7/29
PU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4114 Stock
  4. News Synmosa Biopharma Corporation